Valeriana jatamansi partially reverses liver cirrhosis and tissue hyperproliferative response in rat

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 32, Issue 10, 2010, Pages 713-719

  Prasad, R ^a   Naime, M ^a   Routray, I ^a   Mahmood, A ^a   Khan, F ^a   Ali, Shakir ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; GAMMA GLUTAMYLTRANSFERASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; PLANT EXTRACT; THIOACETAMIDE; UNCLASSIFIED DRUG; VALERIANA JATAMANSI EXTRACT; XANTHINE OXIDASE;

ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HERB; HISTOPATHOLOGY; LIPID PEROXIDATION; LIVER CELL; LIVER CIRRHOSIS; NONHUMAN; RAT; RHIZOME; TREATMENT DURATION; VALERIANA; VALERIANA JATAMANSI;

ADMINISTRATION, ORAL; ALKALINE PHOSPHATASE; ANIMALS; CELL PROLIFERATION; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; INDIA; LIVER CIRRHOSIS, EXPERIMENTAL; LIVER FUNCTION TESTS; MEDICINE, TRADITIONAL; PLANT EXTRACTS; RATS; RATS, WISTAR; THIOACETAMIDE; VALERIAN;

EID: 79954455886     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: 10.1358/mf.2010.32.10.1522224     Document Type: Article

References (34)

1. Torok, N.J. Recent advances in the pathogenesis and diagnosis of liver fibrosis. J Gastroenterol 2008, 43(5): 315-21.
2. Le Bousse-Kerdilès, M.C.B., Martyré, M.C., Samson, M. Cellular and molecular mechanisms underlying bone marrow and liver fibrosis: A review. Eur Cytokine Netw 2008,19(2): 69-80.
3. Bagchi, A., Oshima, Y., Hinkino, H. Neolignans and lignans of Nardostachys jatamansi roots. Planta Med 1991, 57(1): 96-7.
4. Uniyal, M.R., Issar, R.K. Commercially and traditionally important medicinal plants of Mandakini valley of Uttarakhand, Himalayas. Indian J Med Res 1969, 4: 83.
5. Prabhu, V.M., Karanth, S.K., Rao, A. Effect of Nardostachys jatamansi on biogenic amines and inhibitory amino acids on rat brain. Planta Med 1994, 60(2): 114-7.
6. Turner, W. Of spikenerd. A New Herbal (Part II & III), Cambridge University Press, London, 1968.
7. Ali, S., Ansari, K.A., Jafry, M.A., Kabeer, H., Diwakar, G. Nardostachys jatamansi protects against liver damage induced by thioacetamide in rats. J Ethnopharmacol 2000, 71(3): 359-63.
8. Oren, R., Dotan, I., Papa, M. et al. Inhibition of experimentally induced cirrhosis in rats by hypothyroidism. Hepatology 1996, 24(2): 419-23.
9. Shaw, S.R., Nihal, M., Ahmad, N. Dose translation from animal to human studies revisited. FASEB J 2007, 22(3): 659-61.
10. Ali, S., Pawa, S., Naime, M., Prasad, R., Ahmad, T., Farooqui, H., Zafar, H. Role of mammalian cytosolic molybdenum Fe-S flavin hydroxylases in hepatic injury. Life Sci 2008, 82(13-14): 780-8.
11. Kind, P.R.N., King, E.J.J. Estimation of plasma phosphatase by determination of hydrolysed phenol with amino-antipyrine. J Clin Pathol 1954, 7(4): 322-6.
12. Orlowski, M., Meister, A. Gamma-glutamyl cyclotransferase distribution, isozymic forms and specificity. J Biol Chem 1973, 248(8): 2836-44.
13. Bernheim, F., Bernheim, M.L.C., Wilburn, K.M. The reaction between thiobarbituric acid and the oxidation products of certain lipids. J Biol Chem 1948, 174(1): 257-64.
14. Jollow, D.J., Mitchell, J.R., Zampagtrone, N., Gillete, J.R. Bromobenzene induced liver necrosis. Protective role of glutathione and evidence for 3, 4-bromobenzene oxide as the hepatotoxic metabolite. Pharmacology 1974, 11(3): 151-69.
15. Carlberg, I., Mannervick, B. Purification and characterization of the flavoenzymes glutathione reductase from rat liver. J Biol Chem 1975, 250(14): 5475-80.
16. Mohandas, J., Marshall, J.J., Duggin, G.G., Horvarth, J.S., Tiller, D.J. Differential distribution of glutathione and glutathione related enzymes in rabbit kidney. Possible implications in analgesic nephropathy. Biochem Pharmacol 1984, 33(11): 1801-7.
17. Stripe, F., Corte, D.E. The regulations of rat liver xanthine oxidase. Conversion in vitro of the enzyme activity from dehydrogenase (type D) to oxidase (type O). J Biol Chem 1969, 244(14): 3855-63.
18. Habig, W.H., Pabst, M.J., Fleischner, G., Gatmaitan, Z., Arias, I.M., Jakob, W.B. The identity of glutathione-S-transferase B with ligandin, a major binding protein of liver. Proc Natl Acad Sci USA 1974, 71(10): 3879-82.
19. Smart, R.C., Huang, M.T., Conney, A.H. Sn1, 2-diacylglycerols mimic the effects of TPA in vivo by inducing biochemical changes associated with tumor promotion in mouse epidermis. Carcinogenesis 1986, 7(11): 1865-70.
20. Giles, K.W., Myers, A. An improved diphenylamine method for the estimation of deoxyribonucleic acid. Nature 1965, 206: 93.
21. Nissen, N.N., Martin, P. Hepatocellular carcinoma: The high-risk patient. J Clin Gastroenterol 2002, 35(5, Suppl. 2): S79-85.
22. Okita, K., Sakaida, I., Hino, K. Current strategies for chemoprevention of hepatocellular carcinoma. Oncology 2002, 62(Suppl. 1): 24-8.
23. Bataller, R., Brenner, D.A. Liver fibrosis. J Clin Invest 2005, 115(4): 209-18.
24. Baek, S.H., Park, M., Suh, J.H., Choi, H.S. Protective effects of an extract of young radish (Raphanus sativus L.) cultivated with sulfur (sulfur-radish extract) and of sulforaphane on carbon tetrachloride-induced hepatotoxicity. Biosci Biotechnol Biochem 2008, 72(5): 1176-82.
25. Strnad, P., Tao, G.Z., Zhou, Q., Harada, M., Toivola, D.M., Brunt, E.M., Omary, M.B. Keratin mutation predisposes to mouse liver fibrosis and unmasks differential effects of the carbon tetrachloride and thioacetamide models. Gastroenterology 2008, 134(4):1169-79.
26. Zimmermann, T., Muller, A., Machnik, G., Franke, H., Schubert, H., Dargel, R. Biochemical and morphological studies on production and regression of experimental liver cirrhosis induced by thioacetamide in Uje: WIST rats. Z. Versuchstierkd 1987 30(5-6): 165-80.
27. Fontana, L., Moreira, E., Torres, M.I., Fernandez, M.I., Rios, A., Sanchez de Medina, F., Gil, A. Serum amino acid changes in rats with thioacetamide induced liver cirrhosis. Toxicology 1996, 106(1-3): 197-206.
28. Ortega, M.A., Torres, M.I., Fernandez, M.I., Rios, A., Sanchez-Pozo, A., Gil, A. Hepatotoxic agent thioacetamide induces biochemical and histological alterations in rat small intestine. Digest Dis Sci 1997, 42(8): 1715-23.
29. Aris, M.I., Boyer, J.L., Fausto, N., Jakoby, W.B., Schachter, D.A., Shafritz, D.A. (Eds.). The Liver: Biology and Pathology, 3rd Edition, Raven Press, New York 1994.
30. Li, X., Benjamin, I.S.., Alexander, B. Reproducible production of thioacetamide-induced macronodular cirrhosis in the rat with no mortality. J Hepatol 2002, 36(4): 488-93.
31. Ali, S., Diwakar, G., Pawa, S., Siddiqui, M.R., Abdin, M.Z., Ahmad, F.J., Jain, S.K. Xanthine oxidase derived reactive oxygen metabolites contribute to liver necrosis: protection by 4-hydroxypyrazolo [3,4-d] pyrimidine. BBAMol Basis Dis 2001, 1536: 21-30.
32. Poli, G. Pathogenesis of liver fibrosis: Role of oxidative stress. Mol Aspects Med 2000, 21(3): 49-98.
33. Bruck, R., Shirin, H., Aeed, H., Matas, Z., Hochman, A., Pines, M., Avni, Y. Prevention of hepatic cirrhosis in rats by hydroxyl radical scavengers. J Hepatol 2001, 35(4): 457-64.
34. Galli, A., Svegliati, B.G., Ceni, E. et al. Oxidative stress stimulates proliferation and invasiveness of hepatic stellate cells via a MMP2-mediated mechanism. Hepatology 2005, 41(5): 1074-84.